326 related articles for article (PubMed ID: 1279332)
1. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.
Horak ER; Leek R; Klenk N; LeJeune S; Smith K; Stuart N; Greenall M; Stepniewska K; Harris AL
Lancet; 1992 Nov; 340(8828):1120-4. PubMed ID: 1279332
[TBL] [Abstract][Full Text] [Related]
2. [The importance of tumor angiogenesis as a prognostic indicator in primary breast cancer].
Saji S; Toi M; Tominaga T
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):368-74. PubMed ID: 8709939
[TBL] [Abstract][Full Text] [Related]
3. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo.
Berger R; Albelda SM; Berd D; Ioffreda M; Whitaker D; Murphy GF
J Cutan Pathol; 1993 Oct; 20(5):399-406. PubMed ID: 7507944
[TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.
Gasparini G; Toi M; Verderio P; Ranieri G; Dante S; Bonoldi E; Boracchi P; Fanelli M; Tominaga T
Int J Oncol; 1998 May; 12(5):1117-25. PubMed ID: 9538138
[TBL] [Abstract][Full Text] [Related]
6. Correlation between tumor angiogenesis and metastasis in breast cancer.
Chu JS; Lee WJ; Chang TC; Chang KJ; Hsu HC
J Formos Med Assoc; 1995 Jul; 94(7):373-8. PubMed ID: 7549559
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
Heimann R; Ferguson D; Powers C; Recant WM; Weichselbaum RR; Hellman S
J Natl Cancer Inst; 1996 Dec; 88(23):1764-9. PubMed ID: 8944007
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
[TBL] [Abstract][Full Text] [Related]
9. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F
J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma.
Toi M; Kashitani J; Tominaga T
Int J Cancer; 1993 Sep; 55(3):371-4. PubMed ID: 7690738
[TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma.
Axelsson K; Ljung BM; Moore DH; Thor AD; Chew KL; Edgerton SM; Smith HS; Mayall BH
J Natl Cancer Inst; 1995 Jul; 87(13):997-1008. PubMed ID: 7543156
[TBL] [Abstract][Full Text] [Related]
12. Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39.
Kakolyris S; Fox SB; Koukourakis M; Giatromanolaki A; Brown N; Leek RD; Taylor M; Leigh IM; Gatter KC; Harris AL
Br J Cancer; 2000 Feb; 82(4):844-51. PubMed ID: 10732757
[TBL] [Abstract][Full Text] [Related]
13. [The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers].
Charpin-Taranger C; Dales JP; Garcia S; Andrac-Meyer L; Ramuz O; Carpentier-Meunier S; Bonnier P
Bull Acad Natl Med; 2003; 187(6):1129-45; discussion 1145-6. PubMed ID: 14978873
[TBL] [Abstract][Full Text] [Related]
14. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis.
Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
J Pathol; 2001 Mar; 193(3):325-32. PubMed ID: 11241411
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.
Rice AJ; Steward MA; Quinn CM
J Clin Pathol; 2002 Dec; 55(12):921-5. PubMed ID: 12461058
[TBL] [Abstract][Full Text] [Related]
16. CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.
Charpin C; Devictor B; Bergeret D; Andrac L; Boulat J; Horschowski N; Lavaut MN; Piana L
Am J Clin Pathol; 1995 Apr; 103(4):443-8. PubMed ID: 7726141
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors.
Nakopoulou L; Lekkas N; Lazaris AC; Athanassiadou P; Giannopoulou I; Mavrommatis J; Davaris P
Anticancer Res; 1999; 19(5C):4547-53. PubMed ID: 10650809
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis in invasive breast carcinoma: is it associated with parameters of prognostic significance?
Miliaras D; Kamas A; Kalekou H
Histopathology; 1995 Feb; 26(2):165-9. PubMed ID: 7537717
[TBL] [Abstract][Full Text] [Related]
19. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer.
Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF
Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950
[TBL] [Abstract][Full Text] [Related]
20. ELAM selectin expression in breast carcinomas detected by automated and quantitative immunohistochemical assays.
Charpin C; Bergeret D; Garcia S; Andrac L; Martini F; Horschowski N; Choux R; Lavaut MN
Int J Oncol; 1998 May; 12(5):1041-8. PubMed ID: 9538126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
